Surana, R., Schoenfeld, A. J., Kamgar, M., Dumbrava, E. E., Paulson, A. S., Becerra, C. R., Leidner, R. S., Boland, P. M., Hecht, J. R., Kundranda, M. N., Zhang, J. Y., Pelster, M., Yan, Y., Liao, Y., Shin, Y., Paz-Chang, H., Whangbo, J., Ahrorov, A., Cohen, S., Fakih, M. (2026). Initial phase 1 study results of NT-175 engineered T-cell therapy in TP53 R175H–mutated unresectable advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2506